Glyco Liver Profile

One blood test. The complete liver profile.

Inflammation, fibrosis, cirrhosis and hepatocellular carcinoma (HCC) risk.

One result. Four specific markers.

Glyco Liver Profile enables patient risk assessment, monitoring, diagnosis and 5-year prediction of hepatocellular carcinoma (HCC) development using four glycan biomarkers which together provide a clear insight into liver health.

The ultimate risk stratification tool for chronic liver disease

The Glyco Liver Profile is a unique, non-invasive test that provides the clinician with a full picture of liver health regardless of aetiology — all from a single blood sample.

This innovative test addresses the medical and economic costs of chronic liver disease — accounting for approximately 2% of deaths annually — streamlining patient stratification and risk assessment, and improving clinical management and treatment outcomes.

  • Streamline and reduce costs: one kit and serum sample allows you to consolidate screening — reducing time, life costs and complexity for you and patients
  • Stratify and manage patient care: our intuitive four-index results allow you to easily identify and manage patients early with a sensitive, specific profile
  • Predict and save lives: a proven and accurate prognostic method providing automated, long-term assessment for a more complete and consistent picture of disease progression

Watch: Glyco Liver Profile

Learn more

Sign up for more content:

Your full name
Your role or position
Your employer organisation

Learn how we use your data here.

Choose which options you are interested in

More information


Download the Glyco Liver Profile brochure

Click here to view the PDF file

Automation and intelligence

Glyco Liver Profile joins a range of existing tests running on our fully-automated V8 NEXUS capillary electrophoresis system.

  • Serum Proteins
  • Haemoglobins and HbA1c
  • CDT


Home page

You are here:



Molecular Biology products